PGEN Historical PE Ratio Notes

— Precigen (ticker symbol: PGEN) is a biotechnology company focused on developing gene and cell therapies, synthetic biology solutions, and precision medicine platforms. The firm leverages proprietary technology to create innovative treatments in oncology, autoimmune disorders, and infectious diseases. As you research PGEN's historical PE ratio, it’s important to understand that biotechnology companies like Precigen often report negative or highly variable earnings due to significant R&D expenses, lengthy product development cycles, and uncertain regulatory outcomes. This means the PE ratio (price-to-earnings ratio) for PGEN may be non-applicable (N/A), extremely high, or fluctuate dramatically over time, especially before product commercialization or profitability. Historical charts often reflect these dynamics, with periods of negative earnings resulting in an undefined PE ratio. When reviewing PGEN's historical PE data, pay close attention to the context: a low or high PE ratio compared to peers may not necessarily signal undervaluation or overvaluation, but rather the inherent risks & growth opportunities unique to early-stage biotech firms. Understanding this backdrop is crucial for making sense of PGEN’s valuation history.

On this page we presented the PGEN Historical PE Ratio information for Precigen' stock. The average PGEN historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 57.8. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average PGEN historical PE based on this TTM earnings result method is NA. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this PGEN historical PE result, against the recent PE: when this page was posted on 4/2/2026, the most recent closing price for PGEN had been 3.94, and the most recent quarterly earnings result, annualized, was 0.04. Meanwhile, the most recent TTM earnings summed to 0.03. From these numbers, we calculate the recent PGEN PE on 4/2/2026 based on annualized quarterly EPS was 98.5. Based on PGEN's history, that recent PE is elevated relative to the historical average, with the recent PE 70.4% higher than the historical average PE across our data set for Precigen.

For self directed investors doing their due diligence on PGEN or any other given stock, valuation analysis for PGEN can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Precigen PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PGEN. Thanks for visiting, and the next time you need to research PGEN Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.